Results 21 to 30 of about 7,132,139 (192)

The critical points in induction of experimental autoimmune uveitis [PDF]

open access: yesBiomedical Papers, 2016
Background: Autoimmune uveitis is a leading cause of visual impairment in developed countries in patients of working age. Animal models of experimental autoimmune uveitis (EAU) have been established to serve as a useful template for novel therapeutic ...
Aneta Klimova   +5 more
doaj   +3 more sources

Overexpressing Kallistatin Aggravates Experimental Autoimmune Uveitis Through Promoting Th17 Differentiation

open access: yesFrontiers in Immunology, 2021
Kallistatin or kallikrein-binding protein (KBP) has been reported to regulate angiogenesis, inflammation and tumor progression. Autoimmune uveitis is a common, sight-threatening inflammatory intraocular disease.
Nu Chen   +8 more
doaj   +3 more sources

Kallistatin Attenuates Experimental Autoimmune Uveitis by Inhibiting Activation of T Cells

open access: yesFrontiers in Immunology, 2020
Experimental autoimmune uveoretinitis (EAU) is a mouse model of human autoimmune uveitis. EAU spontaneously resolves and is marked by ocular autoantigen-specific regulatory immunity in the spleen.
Fauziyya Muhammad   +9 more
doaj   +3 more sources

Macrophages and Uveitis in Experimental Animal Models [PDF]

open access: yesMediators of Inflammation, 2015
Resident and infiltrated macrophages play relevant roles in uveitis as effectors of innate immunity and inductors of acquired immunity. They are major effectors of tissue damage in uveitis and are also considered to be potent antigen-presenting cells. In
Salvador Mérida   +3 more
doaj   +2 more sources

Targeting CD6 for the treatment of experimental autoimmune uveitis [PDF]

open access: yesJournal of Autoimmunity, 2018
CD6 is emerging as a new target for treating many pathological conditions in which T cells are integrally involved, but even the latest data from studies of CD6 gene engineered mice were still contradictory. To address this issue, we studied experimental autoimmune uveitis (EAU), a model of autoimmune uveitis, in wild-type (WT) and CD6 knockout (KO ...
Zhang, Lingjun   +10 more
openaire   +6 more sources

NK cells are negatively regulated by sCD83 in experimental autoimmune uveitis

open access: yesScientific Reports, 2017
Natural killer (NK) cells represent a subset of lymphocytes that contribute to innate immunity and have been reported to play a role in autoimmune uveitis. However, the mechanisms regulating NK cellular function in this condition remain unclear.
Wei Lin   +8 more
doaj   +3 more sources

IL‐33 attenuates the development of experimental autoimmune uveitis [PDF]

open access: yesEuropean Journal of Immunology, 2014
Interleukin‐33 (IL‐33) is associated with several important immune‐mediated disorders. However, its role in uveitis, an important eye inflammatory disease, is unknown. Here, we investigated the function of IL‐33 in the development of experimental autoimmune uveitis (EAU).
Barbour, Mark   +12 more
openaire   +8 more sources

Integrated omics reveal the effects of vitamin D deficiency on gut microbiota and plasma metabolism in experimental autoimmune uveitis. [PDF]

open access: yesJ Neuroinflammation
Vitamin D deficiency (VD-deficiency) has been implicated in various autoimmune diseases, including uveitis, yet its mechanistic role remains unclear. Emerging evidence suggests that gut microbial dysbiosis and metabolic disturbances may serve as critical
Chen Z   +6 more
europepmc   +2 more sources

Baicalin prevents experimental autoimmune uveitis by promoting macrophage polarization balance through inhibiting the HIF-1α signaling pathway. [PDF]

open access: yesSci Rep
Uveitis is a series of autoimmune eye diseases that can seriously damage people’s eyesight. This study aimed to explore the therapeutic potential of baicalin in treating uveitis, focusing on its modulation of HIF-1α expression and macrophage polarization.
Liu B   +8 more
europepmc   +2 more sources

Therapeutic targeting of STAT3 (signal transducers and activators of transcription 3) pathway inhibits experimental autoimmune uveitis.

open access: yesPLoS ONE, 2012
Mice with targeted deletion of STAT3 in CD4(+) T-cells do not develop experimental autoimmune uveitis (EAU) or experimental autoimmune encephalomyelitis (EAE), in part, because they cannot generate pathogenic Th17 cells.
Cheng-Rong Yu   +4 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy